Literature DB >> 19461020

Current status of stroke risk stratification in patients with atrial fibrillation.

Robert G Hart1, Lesly A Pearce.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19461020     DOI： 10.1161/STROKEAHA.109.549428

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  19 in total

1.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John J You; Daniel E Singer; Patricia A Howard; Deirdre A Lane; Mark H Eckman; Margaret C Fang; Elaine M Hylek; Sam Schulman; Alan S Go; Michael Hughes; Frederick A Spencer; Warren J Manning; Jonathan L Halperin; Gregory Y H Lip
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Choices in the use of ICD-9 codes to identify stroke risk factors can affect the apparent population-level risk factor prevalence and distribution of CHADS2 scores.

Authors:  James A Rothendler; Adam J Rose; Joel I Reisman; Dan R Berlowitz; Lewis E Kazis
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

Review 3.  Prediction of stroke risk in atrial fibrillation, prevention of stroke in atrial fibrillation, and the impact of long-term monitoring for detecting atrial fibrillation.

Authors:  George Thomas; Bruce B Lerman
Journal:  Curr Atheroscler Rep       Date:  2011-08       Impact factor: 5.113

Review 4.  Stroke prevention in atrial fibrillation: putting the guidelines into practice.

Authors:  Jonathan Mant; Duncan Edwards
Journal:  Drugs Aging       Date:  2010-11-01       Impact factor: 3.923

Review 5.  [Device-based remote monitoring : Current evidence].

Authors:  David Duncker; Roman Michalski; Johanna Müller-Leisse; Christos Zormpas; Thorben König; Christian Veltmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-08-15

Review 6.  Impact of Metabolic Syndrome on Ablation-Outcome in Patients with Atrial Fibrillation: A Systematic Review.

Authors:  Sanghamitra Mohanty; Luigi Di Biase; Prasant Mohanty; Pasquale Santangeli; Bai Rong; Trivedy Chintan; David Burkhardt; Joseph G Gallinghouse; Rodney Horton; Javier E Sanchez; Shane Bailey; Jason Zagrodzky; Andrea Natale
Journal:  J Atr Fibrillation       Date:  2013-02-12

Review 7.  Stroke Prevention in Atrial Fibrillation.

Authors:  Michael Katsnelson; Sebastian Koch; Tatjana Rundek
Journal:  J Atr Fibrillation       Date:  2010-10-22

Review 8.  Should Atrial Fibrillation Burden Be A Feature to Guide Thromboembolism Prophylaxis?

Authors:  Molly Sachdev; Emile G Daoud
Journal:  J Atr Fibrillation       Date:  2012-08-20

Review 9.  New Stroke Prophylaxis Options in Atrial Fibrillation Patients.

Authors:  George Thomas; Bruce B Lerman
Journal:  J Atr Fibrillation       Date:  2013-02-12

10.  Use of dabigatran and rivaroxaban in non-valvular atrial fibrillation: one-year follow-up experience in an Italian centre.

Authors:  Mario Schiavoni; Maurizio Margaglione; Antonella Coluccia
Journal:  Blood Transfus       Date:  2017-01-30       Impact factor: 3.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.